Sunshine Biopharma Inc.
13F holders, Q1 2024 (March 31)14holders
2famous investors
$0.06avg. 13F price*
At the end of Q1 2024, 14 institutions reported holding Sunshine Biopharma Inc. in their 13F filings. The largest holders were Renaissance Technologies ($279K), Citadel Advisors ($33K) and Bridgeway Capital Management, LLC ($17K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Sunshine Biopharma Inc.
- CUSIP
- 867781403
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $11K |
| Exits | 4 | $586K |
Ownership 14 holders
| Renaissance Technologies | 0.00% | Add +6823.3% | 4,610,900 | $279K |
| Citadel Advisors | 0.00% | Add +197.2% | 550,514 | $33K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 286,100 | $17K |
| Jane Street Group, LLC | 0.00% | New | 87,610 | $5K |
| Royal Bank of Canada | 0.00% | New | 65,000 | $4K |
| XTX Topco Ltd | 0.00% | Add +207.1% | 53,722 | $3K |
| Geode Capital Management, LLC | 0.00% | No change | 20,179 | $1K |
| Two Sigma Investments, LP | 0.00% | New | 19,196 | $1K |
| HRT Financial LP | 0.00% | New | 18,068 | $1K |
| Bank of America Corp. | 0.00% | No change | 10,000 | $600 |
| Main Street Group, LTD | 0.00% | No change | 222 | $24 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 79 | $5 |
| Osaic Holdings, Inc. | 0.00% | Reduce -91.6% | 68 | $4 |
| UBS Group AG | 0.00% | Reduce -100.0% | 1 | $0 |
"% of holder's portfolio" is SUNSHINE BIOPHARMA INC's weight in each manager's 13F, not the share of Sunshine Biopharma Inc. the manager owns.